Clinical Trials Logo

Warts clinical trials

View clinical trials related to Warts.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06077032 Not yet recruiting - Non-Genital Warts Clinical Trials

Chlorhexidine and Garlic Extract as Potential Topical Virucidal Therapeutic Agents of Non-Genital Warts

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Aim(s) of the Research: 1. Evaluate the efficacy and safety of topical chlorhexidine (2%) solution vs garlic extract (15%) solution in treating non-genital warts. 2. Explore possible relation between therapeutic response with demographic/clinical data. 3. Identify patients satisfaction with each agent.

NCT ID: NCT05902624 Not yet recruiting - Cutaneous Warts Clinical Trials

Efficacy and Safety of Hepatitis B Virus Vaccine(HBV) in Treatment of Cutaneous Warts

Start date: June 10, 2023
Phase: Early Phase 1
Study type: Interventional

Aim of the work: 1. Evaluate efficacy and safety of Intralesional HBV vaccine injection as a treatment of plane and genital warts. 2. Evaluate efficacy and safety of Intramuscular HBV vaccine injection as a treatment of plane and genital warts. 3. Compare the efficacy of different doses(0.3ml vs 0.5ml )of intralesional HBV vaccine injection for treatment of plane and genital warts. 4. Compare the efficacy of intralesional HBV vaccine injection vs Intramuscular HBV vaccine injection in treatment of plane and genital warts.

NCT ID: NCT05781841 Not yet recruiting - Warts Clinical Trials

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Start date: April 15, 2023
Phase:
Study type: Observational

Warts are common epidermal growths caused by various strains of human papilloma virus (HPV). Viral warts are common with a prevalence rate of 7-12%. Human papilloma virus is small non enveloped viruses that contain a double-stranded DNA genome. There are more than 200 HPV genotypes are reported, however, the high-risk types, including HPV genotype-16 (HPV16), 18, 31, and 45, are the causes of 80% of cervical cancers.

NCT ID: NCT05622916 Not yet recruiting - Anogenital Wart Clinical Trials

Topical Ethanol Extract (Piper Crocatum) for Anogenital Warts

Start date: November 30, 2022
Phase: N/A
Study type: Interventional

This clinical trial aims to assess the efficacy of topical Piper crocatum in treating Anogenital warts. It aims to answer - the clinical efficacy of treating anogenital warts - the expression of Foxp3+ regulatory T (Treg), TGF/Tumor Growth Factor -β1, and IFN/interferon -γ of anogenital wart lesion Participants will be allocated into two topical treatments, intervention and active comparator Trichloroacetic Acid (TCA) 90%. The researchers assume that intervention is superior compared to TCA 90%

NCT ID: NCT05617950 Not yet recruiting - Warts Clinical Trials

Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts

Start date: November 2022
Phase: N/A
Study type: Interventional

To evaluate whether salicylic acid was superior to cryotherapy for plantar warts

NCT ID: NCT05616078 Not yet recruiting - Warts Clinical Trials

Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts

Start date: November 2022
Phase: N/A
Study type: Interventional

To evaluate whether laser was superior to cryotherapy for recalcitrant warts

NCT ID: NCT05599971 Not yet recruiting - Plantar Wart Clinical Trials

Intralesional Injection of Combined Digoxin and Furosemide Versus 5-Flurouracil in Plantar Warts

Start date: February 22, 2023
Phase: N/A
Study type: Interventional

The aim of the current work is to evaluate the efficacy and safety of intralesional combined Digoxin and furosemide versus intralesional 5-flurouracil in the treatment of plantar warts.

NCT ID: NCT05324904 Not yet recruiting - Plantar Wart Clinical Trials

Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts

Start date: October 2022
Phase: N/A
Study type: Interventional

To evaluate and compare the efficacy and safety of intralesional acyclovir versus intralesional vitamin D3 in the treatment of plantar warts

NCT ID: NCT05300009 Not yet recruiting - Warts Clinical Trials

Efficacy and Safety of Topical Methotrexate Gel 1% Coupled With Microneedling in Treatment of Warts

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

To study the clinical efficacy of the topically applied MTX hydrogel preparation combined with microneedling to increase drug delivery and efficacy in comparison with cryotherapy in treatment of warts.

NCT ID: NCT05198180 Not yet recruiting - Plantar Wart Clinical Trials

Treatment of Plantar Warts

Start date: February 2022
Phase: Phase 3
Study type: Interventional

This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.